22nd Century Group, a plant biotechnology company and leader in tobacco harm reduction, has announced that it will open specialized laboratories in western New York, USA, dedicated to new scientific research at substantially lower costs Read More
Tags :plant biotechnology
Recent Posts
- Weight-Loss Drugs Suppress Tobacco Cravings
- UKVIA Updates Suppliers on Changing U.K. Landscape
- Altria Reaffirms Guidance
- U.K. Misleading Public About Relative Risk: Gilchrist
- Former Researcher Sues KT&G Over E-cigarette Patents
- Diluted Diligence
- Sampoerna Profit Jumps by One Third
- EU Urged to Adopt Science-Based Strategy
- Social Media Linked to Youth Tobacco Use
- Kenya to Consult on New Health Warnings
- New President at PMFCT
- Civil Money Penalties for 22 Elfbar Sellers
- Brazil Agency Upholds Vaping Sales Ban
- Royal College Releases New E-cig Report
- NCLA Weighs in on Cigar Rules Litigation